The Iranian National Formulary (INF) has more than 2,300 molecules registered at Iran's Ministry of Health, including various strengths and dosage forms. The standards regarding pharmaceutical products in Iran are determined and modified by the Pharmacopeia Council.
Iran has adopted a full generic-based National Drug Policy (NDP), with local production of essential drugs and vaccines as one of the main goals.
Top 20 drug molecules and sales in Iran
+ Top 20 molecules Molecule Sales for the first 6 month of 2010 (in Iranian Rials)1INTERFERON423,996,630,0002CEFIXIME 397,896,015,0003AMOXICILLIN 323,624,414,2644CO-AMOXICLAV 231,047,948,6005ACETAMINOPHEN 210,953,849,4926ALBUMIN 210,632,806,0007DOCETAXEL 182,924,555,6008IMIPENEM+CILASTATAIN 181,099,640,0009CLOPIDOGREL 169,915,498,01510IMMUNE GLOBULIN 160,575,717,00011ENOXAPARIN 145,486,724,60012CEFALEXIN 142,499,418,00013DEXTROSE 141,272,434,00014ATORVASTATIN 132,514,275,60015PANTOPRAZOL 130,971,241,40016SALMETEROL 127,780,028,00017SODIUM CHLORIDE 126,043,613,10018IBUPROFEN 125,621,562,50019RITUXIMAB 118,690,006,00020ERYTHROPOIETIN 110,191,720,000
See also Pharmaceuticals in Iran
References